These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 27554763

  • 1. Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis.
    Boutaud O, Sosa IR, Amin T, Oram D, Adler D, Hwang HS, Crews BC, Milne G, Harris BK, Hoeksema M, Knollmann BC, Lammers PE, Marnett LJ, Massion PP, Oates JA.
    Cancer Prev Res (Phila); 2016 Nov; 9(11):855-865. PubMed ID: 27554763
    [Abstract] [Full Text] [Related]

  • 2. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.
    Guillem-Llobat P, Dovizio M, Bruno A, Ricciotti E, Cufino V, Sacco A, Grande R, Alberti S, Arena V, Cirillo M, Patrono C, FitzGerald GA, Steinhilber D, Sgambato A, Patrignani P.
    Oncotarget; 2016 May 31; 7(22):32462-77. PubMed ID: 27074574
    [Abstract] [Full Text] [Related]

  • 3. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients.
    Frommel TO, Dyavanapalli M, Oldham T, Kazi N, Lietz H, Liao Y, Mobarhan S.
    Clin Cancer Res; 1997 Feb 31; 3(2):209-13. PubMed ID: 9815674
    [Abstract] [Full Text] [Related]

  • 4. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
    Capone ML, Tacconelli S, Sciulli MG, Grana M, Ricciotti E, Minuz P, Di Gregorio P, Merciaro G, Patrono C, Patrignani P.
    Circulation; 2004 Mar 30; 109(12):1468-71. PubMed ID: 15037526
    [Abstract] [Full Text] [Related]

  • 5. Characterization of cyclooxygenase-2 acetylation and prostanoid inhibition by aspirin in cellular systems.
    Tacconelli S, Contursi A, Falcone L, Mucci M, D'Agostino I, Fullone R, Sacco A, Zucchelli M, Bruno A, Ballerini P, Dovizio M, Patrignani P.
    Biochem Pharmacol; 2020 Aug 30; 178():114094. PubMed ID: 32535107
    [Abstract] [Full Text] [Related]

  • 6. Aspirin as a COX inhibitor and anti-inflammatory drug in human skeletal muscle.
    Ratchford SM, Lavin KM, Perkins RK, Jemiolo B, Trappe SW, Trappe TA.
    J Appl Physiol (1985); 2017 Dec 01; 123(6):1610-1616. PubMed ID: 28706001
    [Abstract] [Full Text] [Related]

  • 7. Ascorbic acid enhances the inhibitory effect of aspirin on neuronal cyclooxygenase-2-mediated prostaglandin E2 production.
    Candelario-Jalil E, Akundi RS, Bhatia HS, Lieb K, Appel K, Muñoz E, Hüll M, Fiebich BL.
    J Neuroimmunol; 2006 May 01; 174(1-2):39-51. PubMed ID: 16529823
    [Abstract] [Full Text] [Related]

  • 8. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors.
    Penglis PS, Cleland LG, Demasi M, Caughey GE, James MJ.
    J Immunol; 2000 Aug 01; 165(3):1605-11. PubMed ID: 10903770
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A, Cavalcanti F, Miralles A, Bayón Y, Alonso A, Merlos M, García-Rafanell J, Forn J.
    Mol Pharmacol; 1999 Apr 01; 55(4):753-60. PubMed ID: 10101034
    [Abstract] [Full Text] [Related]

  • 10. Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects.
    Maenthaisong R, Tacconelli S, Sritara P, Del Boccio P, Di Francesco L, Sacchetta P, Archararit N, Aryurachai K, Patrignani P, Suthisisang C.
    Int J Immunopathol Pharmacol; 2013 Apr 01; 26(2):403-17. PubMed ID: 23755755
    [Abstract] [Full Text] [Related]

  • 11. Influence of low-dose aspirin, resistance exercise, and sex on human skeletal muscle PGE2 /COX pathway activity.
    Naruse M, Fountain WA, Claiborne A, Chambers TL, Jones AM, Stroh AM, Montenegro CF, Lynch CE, Minchev K, Trappe S, Trappe TA.
    Physiol Rep; 2021 Mar 01; 9(5):e14790. PubMed ID: 33661544
    [Abstract] [Full Text] [Related]

  • 12. Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma.
    Bak AW, McKnight W, Li P, Del Soldato P, Calignano A, Cirino G, Wallace JL.
    Life Sci; 1998 Mar 01; 62(23):PL 367-73. PubMed ID: 9627095
    [Abstract] [Full Text] [Related]

  • 13. Constitutive cyclooxygenase-1 and induced cyclooxygenase-2 in isolated human iris inhibited by S(+) flurbiprofen.
    van Haeringen NJ, van Sorge AA, Carballosa Coré-Bodelier VM.
    J Ocul Pharmacol Ther; 2000 Aug 01; 16(4):353-61. PubMed ID: 10977131
    [Abstract] [Full Text] [Related]

  • 14. Human pharmacology of naproxen sodium.
    Capone ML, Tacconelli S, Sciulli MG, Anzellotti P, Di Francesco L, Merciaro G, Di Gregorio P, Patrignani P.
    J Pharmacol Exp Ther; 2007 Aug 01; 322(2):453-60. PubMed ID: 17473175
    [Abstract] [Full Text] [Related]

  • 15. Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer.
    Bronger H, Kraeft S, Schwarz-Boeger U, Cerny C, Stöckel A, Avril S, Kiechle M, Schmitt M.
    Breast Cancer Res; 2012 Feb 14; 14(1):R30. PubMed ID: 22333315
    [Abstract] [Full Text] [Related]

  • 16. Theoretical investigation of aspirin dosage regimen to exhibit optimal antiplatelet effects and decrease risk of upper gastrointestinal lesions.
    Yokoyama H, Yaguchi T, Suzuki Y, Tokuoka K, Watanabe M, Kitagawa Y, Yamada Y.
    Biol Pharm Bull; 2012 Feb 14; 35(12):2112-8. PubMed ID: 23047244
    [Abstract] [Full Text] [Related]

  • 17. Role of prostaglandin E2 in the invasiveness, growth and protection of cancer cells in malignant pleuritis.
    Pace E, Siena L, Ferraro M, Profita M, Mondello P, Chiappara G, Montalbano AM, Giarratano A, Bonsignore G, Gjomarkaj M.
    Eur J Cancer; 2006 Sep 14; 42(14):2382-9. PubMed ID: 16899364
    [Abstract] [Full Text] [Related]

  • 18. COX-2 is not involved in thromboxane biosynthesis by activated human platelets.
    Patrignani P, Sciulli MG, Manarini S, Santini G, Cerletti C, Evangelista V.
    J Physiol Pharmacol; 1999 Dec 14; 50(4):661-7. PubMed ID: 10639016
    [Abstract] [Full Text] [Related]

  • 19. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac.
    Chen WS, Wei SJ, Liu JM, Hsiao M, Kou-Lin J, Yang WK.
    Int J Cancer; 2001 Mar 15; 91(6):894-9. PubMed ID: 11275997
    [Abstract] [Full Text] [Related]

  • 20. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE, Gottesdiener K, Huntington M, Wong P, Larson P, Wildonger L, Gillen L, Dorval E, Waldman SA.
    J Clin Pharmacol; 2000 Dec 15; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.